Oryzon Genomics Eulerpool Uudised

Oryzon Genomics aktsia uudised

Oryzon Genomics jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad Oryzon Genomics uudised paneme siia kokku.

• 10. jaanuar ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in January-February
• 2. detsember ·

  Yahoo
  ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
• 24. oktoober ·

  Yahoo
  ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2024
• 1. oktoober ·

  Yahoo
  ORYZON receives minutes from End-of-Phase II meeting with the FDA on the PORTICO-2 Phase III vafidemstat trial in Borderline Personality Disorder
• 23. september ·

  Yahoo
  ORYZON Presents the Final Data From PORTICO, a Global Phase IIb Vafidemstat Trial in Borderline Personality Disorder (BPD), at the European College of Neuropsychopharmacology (ECNP) Congress
• 11. september ·

  Yahoo
  ORYZON Receives “Intention to Grant” Communication for Patent Relating to the Use of Vafidemstat in Borderline Personality Disorder
• 9. september ·

  Yahoo
  ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in First-Line Acute Myeloid Leukemia
• 3. september ·

  Yahoo
  ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat with Additional “Decision to Grant” Communications
• 29. august ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in September
• 31. juuli ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024